Quadrant Capital Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,279
Closed -$235K 2740
2021
Q2
$235K Sell
1,279
-36
-3% -$6.62K 0.03% 342
2021
Q1
$201K Buy
1,315
+627
+91% +$95.8K 0.03% 354
2020
Q4
$107K Sell
688
-62
-8% -$9.64K 0.02% 478
2020
Q3
$86K Buy
750
+282
+60% +$32.3K 0.02% 477
2020
Q2
$53K Buy
468
+129
+38% +$14.6K 0.01% 698
2020
Q1
$33K Sell
339
-474
-58% -$46.1K 0.01% 1078
2019
Q4
$82K Buy
813
+583
+253% +$58.8K 0.01% 1089
2019
Q3
$18K Sell
230
-29
-11% -$2.27K ﹤0.01% 1626
2019
Q2
$28K Sell
259
-631
-71% -$68.2K ﹤0.01% 1500
2019
Q1
$115K Buy
890
+725
+439% +$93.7K 0.02% 736
2018
Q4
$11K Sell
165
-52
-24% -$3.47K ﹤0.01% 1371
2018
Q3
$26K Sell
217
-11
-5% -$1.32K 0.01% 880
2018
Q2
$22K Buy
228
+7
+3% +$675 0.01% 944
2018
Q1
$19K Buy
221
+76
+52% +$6.53K 0.01% 982
2017
Q4
$14K Sell
145
-15
-9% -$1.45K 0.01% 1061
2017
Q3
$18K Buy
160
+51
+47% +$5.74K 0.01% 955
2017
Q2
$10K Sell
109
-163
-60% -$15K ﹤0.01% 1122
2017
Q1
$28K Buy
272
+75
+38% +$7.72K 0.01% 740
2016
Q4
$20K Buy
197
+64
+48% +$6.5K 0.01% 763
2016
Q3
$13K Buy
133
+73
+122% +$7.14K 0.01% 959
2016
Q2
$3K Sell
60
-213
-78% -$10.7K ﹤0.01% 1385
2016
Q1
$33K Buy
273
+90
+49% +$10.9K 0.02% 517
2015
Q4
$30K Sell
183
-551
-75% -$90.3K 0.02% 476
2015
Q3
$113K Buy
734
+2
+0.3% +$308 0.08% 219
2015
Q2
$130K Buy
+732
New +$130K 0.08% 202